{"name": "Omeros",
 "permalink": "omeros",
 "crunchbase_url": "http://www.crunchbase.com/company/omeros",
 "homepage_url": "http://www.omeros.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "Clinical Stage Bio",
 "created_at": "Sun Oct 11 23:23:46 UTC 2009",
 "updated_at": "Wed Oct 27 11:18:39 UTC 2010",
 "overview": "\u003Cp\u003EOmeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       101],
      "assets/images/resized/0008/4223/84223v1-max-150x150.jpg"],
     [[192,
       130],
      "assets/images/resized/0008/4223/84223v1-max-250x250.jpg"],
     [[192,
       130],
      "assets/images/resized/0008/4223/84223v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$63M",
 "funding_rounds":
  [{"round_code": "e",
    "source_url": "http://investor.omeros.com/releasedetail.cfm?ReleaseID=410872",
    "source_description": "Omeros Raises More Than $63 Million in Financing",
    "raised_amount": 63000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 2,
    "funded_day": 12,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Aravis Ventures",
         "permalink": "aravis-ventures",
         "image":
          {"available_sizes":
            [[[150,
               27],
              "assets/images/resized/0004/8028/48028v2-max-150x150.png"],
             [[208,
               38],
              "assets/images/resized/0004/8028/48028v2-max-250x250.png"],
             [[208,
               38],
              "assets/images/resized/0004/8028/48028v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "ARCH Venture Partners",
         "permalink": "arch-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0003/6165/36165v2-max-150x150.png"],
             [[250,
               51],
              "assets/images/resized/0003/6165/36165v2-max-250x250.png"],
             [[300,
               62],
              "assets/images/resized/0003/6165/36165v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "The Grosvenor Funds",
         "permalink": "the-grosvenor-funds",
         "image":
          {"available_sizes":
            [[[105,
               121],
              "assets/images/resized/0003/0324/30324v2-max-150x150.png"],
             [[105,
               121],
              "assets/images/resized/0003/0324/30324v2-max-250x250.png"],
             [[105,
               121],
              "assets/images/resized/0003/0324/30324v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Fund",
         "permalink": "novartis-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0005/9083/59083v2-max-150x150.png"],
             [[250,
               117],
              "assets/images/resized/0005/9083/59083v2-max-250x250.png"],
             [[318,
               150],
              "assets/images/resized/0005/9083/59083v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Southern Cross Venture Partners",
         "permalink": "southern-cross-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0003/0451/30451v1-max-150x150.jpg"],
             [[250,
               65],
              "assets/images/resized/0003/0451/30451v1-max-250x250.jpg"],
             [[320,
               84],
              "assets/images/resized/0003/0451/30451v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Stanley Medical Research Institute",
         "permalink": "stanley-medical-research-institute",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0008/4237/84237v1-max-150x150.jpg"],
             [[250,
               61],
              "assets/images/resized/0008/4237/84237v1-max-250x250.jpg"],
             [[296,
               73],
              "assets/images/resized/0008/4237/84237v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Trevi Health Ventures",
         "permalink": "trevi-health-ventures",
         "image":
          {"available_sizes":
            [[[150,
               73],
              "assets/images/resized/0005/8517/58517v2-max-150x150.png"],
             [[209,
               102],
              "assets/images/resized/0005/8517/58517v2-max-250x250.png"],
             [[209,
               102],
              "assets/images/resized/0005/8517/58517v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "WRF Capital",
         "permalink": "wrf-capital",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0000/2731/2731v1-max-150x150.png"],
             [[200,
               58],
              "assets/images/resized/0000/2731/2731v1-max-250x250.png"],
             [[200,
               58],
              "assets/images/resized/0000/2731/2731v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "",
    "address2": "",
    "zip_code": "",
    "city": "",
    "state_code": null,
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Billionaire Allen helps inject $25M into Seattle's Omeros\r\n",
    "stoned_year": 2010,
    "stoned_month": 10,
    "stoned_day": 25,
    "source_url": "http://www.fiercebiotech.com/story/billionaire-allen-helps-inject-25m-seattles-omeros/2010-10-25?utm_medium=rss\u0026utm_source=rss",
    "source_text": "",
    "source_description": "Billionaire Allen helps inject $25M into Seattle's Omeros",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Omeros",
      "permalink": "omeros"}}],
 "ipo":
  {"valuation_amount": 68200000.0,
   "valuation_currency_code": "USD",
   "pub_year": 2009,
   "pub_month": 10,
   "pub_day": 8,
   "stock_symbol": "OMER"},
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        89],
       "assets/images/resized/0008/4224/84224v1-max-150x150.jpg"],
      [[250,
        149],
       "assets/images/resized/0008/4224/84224v1-max-250x250.jpg"],
      [[450,
        269],
       "assets/images/resized/0008/4224/84224v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}